3Siemelink MA, Zeller T. Biomarkers of coronary artery disease:the promise of the transcrlptome [ J ]. Curt Cardiol Rep, 2014,16 ( 8 ) : 513-518.
4Petrovic D. The role of vascular endothelial growth factor gcne as tile genetic marker of atherothrombotic disorders and in the gene therapy of coronary artery disease [ J ]. Cardiovasc Hematol Agents Med Chem,2010,8 ( 1 ) :47-54.
5Morbidelli CH, Chang JG, Douglas HJ,et al. Nitric oxide mediates mi- togenic effect of VEGF on coronary venular endothelium [ J ]. Am J Physiol, 1996,270 ( 1 Pt 2 ) : H411 -H415.
6Lindahl B, Toss H, Siegbahn A, et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coro- nary artery disease [ J ]. N Engl J Med,2000,343 ( 16 ) : 1139-1147.
9Zhao Q, Egashira K, lnoue S,et al. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/acti- vating monocytes in a rat model of long-term inhibition of nitric oxide synthesis [J]. Circulation,2002,105 ( 9 ) : 1110-1115.
